2021 - 2021 Validation study of the open ADAMTS13 conformation assay as a novel biomarker for correct diagnosis and predicting relapse in immune mediated thrombotic thrombocytopenic purpura
Immune-mediated TTP patients in remission with recovered ADAMTS13 activity but an open ADAMTS13 conformation are at risk for earlier ADAMTS13 relapse
(Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2023 2023)
ADAMTS13 Conformation and Immunoprofiles in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
(65th ASH ANNUAL MEETING & EXPOSITION 2022)
Relationship between recurrence of congenital and immune-mediated thrombotic thrombocytopenic purpura and mRNA-based COVID-19 vaccination : A questionnaire survey in a Japanese cohort
(Immunoprofiles and open ADAMTS13 in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura 2022)
Immunoprofiles and open ADAMTS13 in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
(Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 2022)
2018/12 - American Society of Hematology Abstract Achievement Award “Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Fac tor A1 Domain on Platelet Thrombosis Formation (#113948)”
全件表示
所属学会 (7件):
Belgian society of thrombosis and hemostasis
, International Society of Thrombosis and Haemostasis
, 日本輸血・細胞治療学会
, 日本血栓止血学会
, 日本血液学会
, 日本内科学会
, 日本組織適合性学会